4//SEC Filing
Janda Kim 4
Accession 0001209191-21-053982
CIK 0000850261other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 8:13 PM ET
Size
5.6 KB
Accession
0001209191-21-053982
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Award
Stock option (right to buy)
2021-08-30+250,000→ 250,000 totalExercise: $8.86Exp: 2031-08-30→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001518466
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 8:13 PM ET
- Size
- 5.6 KB